L3VLUP
ProSign in

ABT in the 13F filings

Abbott Laboratories · CUSIP 002824100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 10 Feb 2025
Managers listing it
22
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 21 listed it in both
Shares listed
146,827,556
combined, among listed positions
Reported value
$16.6bn
combined, at the quarter end

Among the 94 comparable managers: 9 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ABT in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

22 of 22 holders

ActionFiling
Capital Research Global Investors54,097,005$6.1bn1.26%Added+795,07313 Feb 2025 (the filing on sec.gov)
Wellington Management Group LLP26,392,302$3.0bn0.55%Added+581,32512 Feb 2025 (the filing on sec.gov)
MFS Investment Management12,811,351$1.4bn0.46%Trimmed-507,99612 Feb 2025 (the filing on sec.gov)
Polen Capital Management LLC12,688,363$1.4bn3.88%Trimmed-1,249,24710 Feb 2025 (the filing on sec.gov)
Fidelity (FMR LLC)9,113,620$1.0bn0.06%Trimmed-168,6695 Nov 2026 (the filing on sec.gov)
Invesco Ltd9,018,429$1.0bn0.19%Added+1,948,32913 Feb 2025 (the filing on sec.gov)
Janus Henderson Group Ltd5,662,369$640m0.33%Added+91,00714 Feb 2025 (the filing on sec.gov)
AllianceBernstein LP3,844,598$435m0.15%Trimmed-318,53612 Feb 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc3,795,355$429munder 0.1%Trimmed-255,14614 Feb 2025 (the filing on sec.gov)
Neuberger Berman Group LLC2,905,507$329m0.26%Added+398,33513 Feb 2025 (the filing on sec.gov)
AQR Capital Management LLC1,494,128$169m0.22%Added+166,34214 Feb 2025 (the filing on sec.gov)
Two Sigma Advisers LP1,393,082$158m0.36%Trimmed-2,515,11814 Feb 2025 (the filing on sec.gov)
Capital World Investors1,338,641$151munder 0.1%Added+1,41013 Feb 2025 (the filing on sec.gov)
Acadian Asset Management LLC1,048,689$119m0.34%Added+292,48111 Feb 2025 (the filing on sec.gov)
Holocene Advisors LP396,699$45m0.14%Trimmed-465,57114 Feb 2025 (the filing on sec.gov)
Two Sigma Investments LP305,352$35m0.08%Trimmed-1,621,19614 Feb 2025 (the filing on sec.gov)
Walleye Capital LLC222,038$25m0.06%Trimmed-43,56913 Feb 2025 (the filing on sec.gov)
Bridgewater Associates LP191,726$22m0.10%Trimmed-515,88913 Feb 2025 (the filing on sec.gov)
Woodline Partners LP53,015$6.0munder 0.1%Newnew14 Feb 2025 (the filing on sec.gov)
GAMCO Investors Inc22,230$2.5munder 0.1%Trimmed-34013 Feb 2025 (the filing on sec.gov)
Dodge & Cox17,857$2.0munder 0.1%Held013 Feb 2025 (the filing on sec.gov)
PDT Partners LLC15,200$1.7m0.15%Held014 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
28 in Q3 2024 to 36 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ABT by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201321$3.5bnn.a.n.a.
Q3 201324$3.3bnn.a.n.a.
Q4 201321$4.0bnn.a.n.a.
Q1 201421$3.8bnn.a.n.a.
Q2 201429$4.9bnn.a.n.a.
Q3 201427$5.3bnn.a.n.a.
Q4 201425$5.9bnn.a.n.a.
Q1 201523$5.7bnn.a.n.a.
Q2 201525$6.5bnn.a.n.a.
Q3 201533$5.9bnn.a.n.a.
Q4 201524$6.5bnn.a.n.a.
Q1 201624$6.0bnn.a.n.a.
Q2 201627$5.7bnn.a.n.a.
Q3 201623$6.0bnn.a.n.a.
Q4 201625$5.5bnn.a.n.a.
Q1 201720$8.1bnn.a.n.a.
Q2 201717$10.5bnn.a.n.a.
Q3 201716$12.8bnn.a.n.a.
Q4 201719$14.8bnn.a.n.a.
Q1 201822$16.2bnn.a.n.a.
Q2 201817$16.9bnn.a.n.a.
Q3 201823$20.0bnn.a.n.a.
Q4 201819$20.1bnn.a.n.a.
Q1 201923$21.8bnn.a.n.a.
Q2 201918$22.5bnn.a.n.a.
Q3 201921$21.5bnn.a.n.a.
Q4 201921$22.4bnn.a.n.a.
Q1 202024$18.7bnn.a.n.a.
Q2 202027$20.7bnn.a.n.a.
Q3 202027$24.7bnn.a.n.a.
Q4 202029$24.8bnn.a.n.a.
Q1 202131$27.6bnn.a.n.a.
Q2 202129$26.5bnn.a.n.a.
Q3 202134$25.4bnn.a.n.a.
Q4 202128$29.2bnn.a.n.a.
Q1 202234$24.2bnn.a.n.a.
Q2 202233$21.5bnn.a.n.a.
Q3 202230$18.8bnn.a.n.a.
Q4 202225$20.6bnn.a.n.a.
Q1 202332$19.2bnn.a.n.a.
Q2 202327$20.4bnn.a.n.a.
Q3 202330$17.7bnn.a.n.a.
Q4 202324$21.0bn1312
Q1 202427$20.6bn1712
Q2 202437$16.8bn2313
Q3 202428$17.7bn1119
Q4 202422$16.6bn911
Q1 202528$20.9bn1811
Q2 202526$21.1bn1413
Q3 202520$21.3bn1110
Q4 202525$20.6bn1818
Q1 202635$19.1bn3012
Q2 202636$15.8bn2321

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ABT and LLY →ABT and JNJ →ABT and VRTX →Choose a stock to compare with ABT →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ABT, latest filings →Back to the 13F Explorer →